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The skin contains two types of dendritic cells (DC),
Langerhans cells (LC), which reside in the epidermis in
close contact with keratinocytes, and dermal dendritic
cells (DDC), resident in the dermis. LC and DDC pro-
cess cutaneous antigens and migrate out of the skin into
the draining lymph nodes to present antigens to T and
B cells. Recent reports showed that LC and DDC play
an important role in certain virus infections, such as
HIV-1 and HSV. Because of the strategic position of LC
and DDC at mucosal sites of infection and the ability of
these cells to capture pathogens, we hypothesized that
these cells could be infected with KSHV and have an
important role in the development of Kaposi’s sarcoma.
We have previously shown that KSHV enters monocyte-
derived dendritic cells (MoDC) through DC-SIGN,
resulting in a nonproductive infection. We have now
generated LC and DDC from pluripotent cord blood
CD34+ precursors by culture with GM-CSF, TNF, and
TGF-B to obtain LC, and GM-CSF, TNF, and IL4 to
generate DDC. These expressed the typical phenotype of
LC, i.e., CD207 pos, CD14pos, CD11b neg, CD1apos, HLA-
DRpos, DC-SIGN neg, and dermal DC, i.e., DC-SIGNpos,
CD14 neg, CD11bpos, CD1apos, HLA-DRpos, langerinneg.
We found that both LC and DDC supported productive
infection with KSHV. Strikingly, while the level of viral
DNA replication increased only 4-fold in infected DDC
by 24h, we observed a >1 log10 increase in levels of viral
DNA in LC. Anti-DC-SIGN mAB inhibited viral infec-
tion of DDC as detected by expression of viral proteins
and viral DNA, while blocking of langerin on LC did
not interfere with viral entry and replication. Infection
with KSHV did not alter cell surface expression of lan-
gerin on LC, but downregulated expression of DC-SIGN
on DDC, as we previously reported for MoDC. Cytokine
production in infected LC and DDC was also altered
compared to uninfected cells, with an increase in the
levels of IL-8, IL-6, and IL-10 in the infected cells.
These results indicate that KSHV can target both LC
and DDC for productive infection and alter their func-
tion, supporting a role for these dermal DC in KSHV
infection and pathogen.
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